Participants

INSERM is the French National Institute of Health and Medical Research. It is a public scientific and technological institute, which operates under the joint authority of the French Ministry of Health and French Ministry of Research. The ANRS is the French Agency for Research on HIV/AIDS and viral hepatitis which since 2012 has been an autonomous agency within Inserm. (France) www.inserm.fr www.anrs.fr

5 teams from Inserm/ANRS will participate to the PoC-HCV project :

Team 1: Matthew Albert Inserm U818/Institut Pasteur

Team 2: Stanislas Pol Inserm U567/Instiut Cochin

Team 3: Arnaud Fontanet ANRS/Institut Pasteur

Team 4: Laurent Abel Inserm U980/University Paris Descartes

Team 5: Yazdan Yazdanpanah Inserm U995/Université Lille

Inserm Transfert is specialised in technology transfer, legal affairs & business negotiation with industry, as well as EU project management. (France)www.inserm-transfert.fr

Biosurfit developed Spinit®, a proprietary technological platform for the point-of-care testing market. Their goal is to deliver results in a matter of minutes translating into fast and accurate predictive tests and improved patient care. (Portugal) www.biosurfit.com

Qlucore is an industry driver in the development of user- friendly software tools for analysing and integrating complex data sets. (Sweden) www.qlucore.com

We are seeking strategic partnerships with NGOs and national health and development agencies to implement these point-of-care tests. If you are interested in such a partnership please contact us.

PoC-HCV is a European research project supported by the European Commission (Grant agreement n° 601851).